A real-world study of the efficacy and safety of anti-programmed cell death-1 therapy combined with chemotherapy or targeted therapy in patients with advanced biliary tract cancer

BACKGROUND: Immune checkpoint inhibitors (ICIs) represent a breakthrough in cancer treatment. However, they have rarely been used to treat biliary tract cancer (BTC). In the current study, we aimed to evaluate and compare the efficacy and safety of anti-programmed cell death-1 (PD-1) therapy used al...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Gastrointest Oncol
Asıl Yazarlar: Sun, Danyang, Ma, Junxun, Wang, Jinliang, Wang, Lijie, Zhang, Sujie, Chen, Guangying, Li, Xiaoyan, Cui, Pengfei, Zheng, Xuan, Hu, Yi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807271/
https://ncbi.nlm.nih.gov/pubmed/33457011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-562
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller